{"id":"https://openalex.org/W2907986975","doi":"https://doi.org/10.1111/dom.13626","title":"Double\u2010blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 diabetes: The CompoSIT\u2010M study","display_name":"Double\u2010blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 diabetes: The CompoSIT\u2010M study","publication_year":2019,"publication_date":"2019-01-04","ids":{"openalex":"https://openalex.org/W2907986975","doi":"https://doi.org/10.1111/dom.13626","mag":"2907986975","pmid":"https://pubmed.ncbi.nlm.nih.gov/30609212","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6593795"},"language":"en","primary_location":{"id":"doi:10.1111/dom.13626","doi":"https://doi.org/10.1111/dom.13626","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.13626","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13626","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13626","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086072427","display_name":"Juan P. Fr\u00edas","orcid":"https://orcid.org/0000-0001-9486-1255","observed_orcids":["https://orcid.org/0000-0001-9486-1255"]},"institutions":[{"id":"https://openalex.org/I4210111119","display_name":"National Research Institute","ror":"https://ror.org/02201aj62","country_code":"US","type":"other","lineage":["https://openalex.org/I4210111119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juan P. Frias","raw_affiliation_strings":["National Research Institute, Los Angeles, California"],"raw_orcid":"https://orcid.org/0000-0001-9486-1255","affiliations":[{"raw_affiliation_string":"National Research Institute, Los Angeles, California","institution_ids":["https://openalex.org/I4210111119"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Zachary Zimmer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zachary Zimmer","raw_affiliation_strings":["MRL, Merck &amp; Co., Inc. Kenilworth New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRL, Merck &amp; Co., Inc. Kenilworth New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104521823","display_name":"Raymond L. H. Lam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raymond L.H. Lam","raw_affiliation_strings":["MRL, Merck &amp; Co., Inc. Kenilworth New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRL, Merck &amp; Co., Inc. Kenilworth New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034679379","display_name":"G. Su\u00e1rez Amor\u00edn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guillermo Amorin","raw_affiliation_strings":["MRL, Merck &amp; Co., Inc. Kenilworth New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRL, Merck &amp; Co., Inc. Kenilworth New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011509805","display_name":"Catherine Ntabadde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Ntabadde","raw_affiliation_strings":["MRL, Merck &amp; Co., Inc. Kenilworth New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRL, Merck &amp; Co., Inc. Kenilworth New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066865652","display_name":"Carol Iredale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carol Iredale","raw_affiliation_strings":["MRL, Merck &amp; Co., Inc. Kenilworth New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRL, Merck &amp; Co., Inc. Kenilworth New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049530400","display_name":"Edward A. O\u2019Neill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward A. O'Neill","raw_affiliation_strings":["MRL, Merck &amp; Co., Inc. Kenilworth New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRL, Merck &amp; Co., Inc. Kenilworth New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031476174","display_name":"Samuel S. Engel","orcid":"https://orcid.org/0000-0002-4439-6356","observed_orcids":["https://orcid.org/0000-0002-4439-6356"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samuel S. Engel","raw_affiliation_strings":["MRL, Merck &amp; Co., Inc. Kenilworth New Jersey"],"raw_orcid":"https://orcid.org/0000-0002-4439-6356","affiliations":[{"raw_affiliation_string":"MRL, Merck &amp; Co., Inc. Kenilworth New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027357772","display_name":"Keith D. Kaufman","orcid":"https://orcid.org/0000-0002-9919-9915","observed_orcids":["https://orcid.org/0000-0002-9919-9915"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith D. Kaufman","raw_affiliation_strings":["MRL, Merck &amp; Co., Inc. Kenilworth New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRL, Merck &amp; Co., Inc. Kenilworth New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053884502","display_name":"Hideo Makimura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hideo Makimura","raw_affiliation_strings":["MRL, Merck &amp; Co., Inc. Kenilworth New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRL, Merck &amp; Co., Inc. Kenilworth New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048833820","display_name":"Michael F. Crutchlow","orcid":"https://orcid.org/0000-0002-9686-9047","observed_orcids":["https://orcid.org/0000-0002-9686-9047"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael F. Crutchlow","raw_affiliation_strings":["MRL, Merck &amp; Co., Inc. Kenilworth New Jersey"],"raw_orcid":"https://orcid.org/0000-0002-9686-9047","affiliations":[{"raw_affiliation_string":"MRL, Merck &amp; Co., Inc. Kenilworth New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5048833820"],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":1.2172,"has_fulltext":true,"cited_by_count":12,"citation_normalized_percentile":{"value":0.79550286,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"21","issue":"5","first_page":"1128","last_page":"1135"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.949999988079071},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9729999899864197},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9229999780654907},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8519999980926514},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8169999718666077},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.44999998807907104},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.49000000953674316},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5640000104904175},{"id":"https://openalex.org/keywords/treatment-intensification","display_name":"treatment intensification","score":0.3529999852180481},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.98084956407547},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.9226325750350952},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8071091175079346},{"id":"https://openalex.org/C2910260750","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin Phosphate","level":5,"score":0.7367362380027771},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7221857905387878},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6820122599601746},{"id":"https://openalex.org/C2778763485","wikidata":"https://www.wikidata.org/wiki/Q419770","display_name":"Dipeptidyl peptidase-4 inhibitor","level":4,"score":0.6542965769767761},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6112641096115112},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.541414737701416},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.48830604553222656},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4241037964820862},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.40067723393440247},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33956751227378845},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3344523310661316},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3208200931549072},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068900","descriptor_name":"Sitagliptin Phosphate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068900","descriptor_name":"Sitagliptin Phosphate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/dom.13626","doi":"https://doi.org/10.1111/dom.13626","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.13626","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13626","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6593795","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6593795","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Obes Metab","raw_type":"Text"},{"id":"pmid:30609212","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30609212","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/dom.13626","doi":"https://doi.org/10.1111/dom.13626","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.13626","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13626","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307776","display_name":"Merck","ror":"https://ror.org/02891sr49"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2907986975.pdf","grobid_xml":"https://content.openalex.org/works/W2907986975.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1972329806","https://openalex.org/W1996407482","https://openalex.org/W2006385105","https://openalex.org/W2026068973","https://openalex.org/W2055864845","https://openalex.org/W2059241568","https://openalex.org/W2102511839","https://openalex.org/W2113901579","https://openalex.org/W2156990409","https://openalex.org/W2160088494","https://openalex.org/W2171512247","https://openalex.org/W2325963726","https://openalex.org/W2507901651","https://openalex.org/W2748858803","https://openalex.org/W2800977298","https://openalex.org/W2888185938","https://openalex.org/W2916996193","https://openalex.org/W4255037836"],"related_works":["https://openalex.org/W2018192866","https://openalex.org/W2016565181","https://openalex.org/W2900239288","https://openalex.org/W2496840989","https://openalex.org/W1966469183","https://openalex.org/W2171512247","https://openalex.org/W2113901579","https://openalex.org/W2102511839","https://openalex.org/W1994832750","https://openalex.org/W2171667655"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"characterize":[2],"the":[3,11,86,132,163,198,203,207,272],"glycaemic":[4,279],"efficacy":[5],"and":[6,48,52,150,160,216,281,288],"safety":[7,253,287],"of":[8,10,37,99,115,186,266,269,274],"initiation":[9],"dipeptidyl":[12],"peptidase-4":[13],"inhibitor":[14],"sitagliptin":[15,62,90,159,199,270],"during":[16,97],"metformin":[17,58,73,100,275,292],"dose":[18,36,265,276],"escalation":[19],"in":[20,101,140,166,197,202,206,217,248],"people":[21],"with":[22,44,158,219,239,285],"type":[23],"2":[24],"diabetes":[25],"(T2D)":[26],"not":[27,258],"at":[28,104,192,259,271],"glycated":[29],"haemoglobin":[30],"(HbA1c)":[31],"goal":[32,261,283],"on":[33,55,262],"a":[34,220,263],"sub-maximal":[35,264],"metformin.":[38],"MATERIALS":[39],"AND":[40],"METHODS:":[41],"Study":[42],"participants":[43,117,257],"HbA1c":[45,103,119,141,172,188,222,260,282],"\u226558":[46],"mmol/mol":[47,50,121,144,152,175,190,224],"\u226497":[49],"(\u22657.5%":[51],"\u226411.0%)":[53],"while":[54],"1000":[56],"mg/d":[57],"were":[59,70,127,142,233],"randomized":[60],"to":[61,71,74,84,93,241,291],"100":[63],"mg":[64],"once":[65],"daily":[66],"or":[67,251],"placebo.":[68],"All":[69],"uptitrate":[72],"2000":[75],"mg/d.":[76],"A":[77,113],"longitudinal":[78],"data":[79],"analysis":[80],"model":[81],"was":[82,173,195],"used":[83],"test":[85],"primary":[87],"hypothesis":[88],"that":[89],"is":[91],"superior":[92],"placebo":[94,204],"when":[95],"initiated":[96],"uptitration":[98,277,293],"reducing":[102],"week":[105,193],"20.":[106],"[ClinicalTrials.gov":[107],"Identifier:":[108],"NCT02791490,":[109],"EudraCT:":[110],"2015-004224-59]":[111],"RESULTS:":[112],"total":[114],"458":[116],"(mean":[118],"71.1":[120],"[8.7%],":[122],"T2D":[123],"duration":[124],"6.3":[125],"years)":[126],"treated.":[128],"After":[129],"20":[130,194],"weeks,":[131],"least":[133],"squares":[134],"(LS)":[135],"mean":[136,168],"changes":[137,169,247],"from":[138,170],"baseline":[139,171,221],"-12.1":[143],"(-14.0,":[145],"-10.1)":[146],"(-1.10%":[147],"[-1.28,":[148],"-0.93])":[149],"-7.6":[151],"(-9.6,":[153],"-5.6)":[154],"(-0.69%":[155],"[-0.88,":[156],"-0.51])":[157],"placebo,":[161],"respectively;":[162],"between-group":[164],"difference":[165],"LS":[167],"-4.5":[174],"(-6.5,":[176],"-2.5)":[177],"(-0.41%":[178],"[-0.59,":[179],"-0.23]);":[180],"P":[181,213,229],"<":[182],"0.001.":[183],"The":[184],"likelihood":[185],"having":[187],"<53":[189],"(<7.0%)":[191],"higher":[196],"group":[200,205],"than":[201],"overall":[208],"population":[209],"(relative":[210,226],"risk":[211,227],"1.7,":[212],"=":[214,230],"0.002)":[215],"those":[218],"\u226569":[223],"(\u22658.5%)":[225],"2.4,":[228],"0.026).":[231],"There":[232],"no":[234],"notable":[235],"differences":[236],"between":[237],"groups":[238],"regard":[240],"adverse":[242],"events":[243],"overall,":[244],"hypoglycaemia":[245],"events,":[246],"body":[249],"weight":[250],"other":[252],"variables.":[254],"CONCLUSION:":[255],"In":[256],"metformin,":[267],"addition":[268],"time":[273],"improved":[278],"response":[280],"attainment,":[284],"similar":[286],"tolerability,":[289],"compared":[290],"alone.":[294]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-01-11T00:00:00"}